Tirzepatide Side Effects
Tirzepatide side effects include nausea (31%), diarrhea (23%), and constipation (13%). Incidence rates, management tips, and when to seek medical help.
Nausea rate
31% (at 15mg)
Diarrhea rate
23% (at 15mg)
Vomiting rate
13% (at 15mg)
Discontinuation (GI)
~4-6%
Injection reactions
3-5%
Common Side Effects and Rates
Tirzepatide's side effect profile is similar to other GLP-1 medications, with gastrointestinal effects predominating. In the SURMOUNT-1 trial (Zepbound), incidence rates at the 15mg dose were: nausea (31%), diarrhea (23%), vomiting (13%), constipation (13%), decreased appetite (10%), dyspepsia (9%), and abdominal pain (6%).
Notably, tirzepatide's GI side effect rates are somewhat lower than semaglutide's despite producing greater weight loss. This may be related to the GIP receptor activation, which has been suggested to have a protective effect on GI tolerance. The dual mechanism may allow weight loss through energy expenditure pathways that don't rely as heavily on GI effects.
Managing GI Side Effects
The same management strategies effective for semaglutide apply to tirzepatide: eat smaller, more frequent meals; avoid fatty and fried foods during titration; stay well-hydrated; and consider evening injection timing. The 2.5mg starting dose is an initiation dose designed purely for GI tolerance and is not therapeutic.
Tirzepatide's titration schedule allows for 2.5mg increments, providing more flexibility to find the right dose. Many patients find their sweet spot at 7.5mg or 10mg rather than going to the maximum 15mg. Your provider should evaluate your response at each dose level.
Serious Risks
Like other GLP-1 medications, tirzepatide carries risks of pancreatitis (rare), gallbladder disease, thyroid C-cell tumors (observed in rodent studies), and acute kidney injury secondary to dehydration. Severe allergic reactions including anaphylaxis have been reported rarely.
The dual GIP/GLP-1 mechanism does not appear to introduce unique serious risks compared to GLP-1-only medications. Long-term safety data is still accumulating, but the Eli Lilly pharmacovigilance program has not identified unexpected safety signals beyond the known class effects.
Injection Site Reactions
Injection site reactions occur in approximately 3-5% of tirzepatide users. These are typically mild and include redness, itching, or swelling at the injection site. Rotating injection sites between the abdomen, thigh, and upper arm helps minimize these reactions.
The KwikPen delivery device is designed for ease of use with a hidden needle. Most patients report less injection anxiety compared to their expectations, and the weekly dosing schedule means only 52 injections per year.
Comparison with Semaglutide Side Effects
Head-to-head data from SURPASS-2 (comparing tirzepatide to semaglutide 1mg for diabetes) showed similar overall GI side effect rates. However, tirzepatide's wider dose range (2.5mg to 15mg in 2.5mg steps) may allow more gradual titration for sensitive patients.
Patients who experience intolerable side effects on semaglutide sometimes tolerate tirzepatide better, and vice versa. Individual response to the GIP component may explain these differences. If one GLP-1 medication causes significant issues, switching to the other is a reasonable strategy.
Frequently Asked Questions
Is tirzepatide easier to tolerate than semaglutide?
Some data suggests slightly lower GI side effect rates with tirzepatide despite greater weight loss. Individual response varies, and some patients tolerate one better than the other. The dual mechanism may provide GI protective effects.
What are the worst side effects of Mounjaro?
The most common bothersome side effect is nausea during dose titration. Serious but rare risks include pancreatitis, gallbladder disease, and allergic reactions. Most GI side effects improve within weeks at each dose level.
Does Zepbound cause hair loss?
Hair loss (telogen effluvium) has been reported by some patients, likely related to rapid weight loss rather than the medication directly. Adequate protein intake and nutrition can help minimize this risk.
How long do Mounjaro side effects last?
GI side effects typically peak during the first 2-3 weeks at each new dose and improve with time. Most patients report significant improvement after 4-6 weeks at their maintenance dose.
Find providers offering personalized tirzepatide management
Compare pricing, reviews, and availability across 18,000+ GLP-1 providers nationwide.
Search Providers →Explore all Tirzepatide topics
Cost guides, side effect management, dosing information, insurance coverage, and more — all backed by clinical data.